Downstream signaling processes that have been associated with the ERβ-mediated inhibition of growth in ovarian cancer cells include the decreased expression of pRb [25], phospho-AKT [25], cyclin D1 [25] and cyclin A2 [25,44] and increased expression of p21 [44]. The gene discussed is ESR2; the disease is ovarian carcinoma.